NCT03435536 2025-11-28
ICAPAC
University Hospital, Toulouse
Phase NA Completed
Clinical Trials
11 trialsNCT04774198 2025-04-06
Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy
Rigshospitalet, Denmark
Completed
NCT04560270 2020-09-23
CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer
Poitiers University Hospital
Phase NA Completed
NCT02887599 2019-01-16
Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities
Yonsei University
Phase NA Completed
NCT02500004 2018-08-03
BAT-Cachexia
Maastricht University Medical Center
Phase NA Completed
NCT00805688 2018-03-06
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
Completed
NCT01392027 2017-11-08
SPORE-PANC
University of Michigan
Phase NA Completed
NCT02241187 2017-09-27
Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01794676 2017-06-16
MEN1
Jersey Shore University Medical Center
Completed
NCT00225745 2015-10-14
Ghrelin Levels in Pancreatic Cancer Patients
Dartmouth-Hitchcock Medical Center
Completed
NCT00582699 2014-04-10
Depression, Cytokines and Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Completed